- Report
- November 2023
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- June 2023
- 338 Pages
Global
From €7239EUR$7,500USD£6,210GBP
- Report
- May 2021
- 250 Pages
Global
From €8639EUR$8,950USD£7,410GBP
Simbrinza is a brand of eye drops used to treat glaucoma and ocular hypertension. It is a combination of two active ingredients, brinzolamide and brimonidine tartrate, which work together to reduce intraocular pressure. Simbrinza is a prescription medication and is available in both single-use and multi-dose bottles. It is typically used once or twice daily, depending on the severity of the condition.
Simbrinza is part of a larger market of optical disorder drugs, which includes medications used to treat a variety of eye conditions, such as glaucoma, cataracts, and macular degeneration. These drugs are typically used to reduce intraocular pressure, improve vision, and slow the progression of the disease.
Some companies in the Simbrinza market include Alcon, Bausch + Lomb, Allergan, and Santen Pharmaceuticals. Show Less Read more